Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-11

Clinical Trial Update: Iloperidone Augmentation of SSRIs for Patients With Major Depressive Disorder With Residual Anger and Irritability [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating augmentation of SSRIs with iloperidone in adults with major depressive disorder and residual anger/irritability. Results have been post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Iloperidone (iloperidone)

Snippet

Sponsor: Maurizio Fava, MD | Conditions: Major Depressive Disorder | Phase 4 | Status: COMPLETED | Results posted: 2017-04-11